{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T14:44:19Z","timestamp":1791902659437,"version":"4.3.4"},"reference-count":5,"publisher":"Oxford University Press (OUP)","license":[{"start":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T00:00:00Z","timestamp":1782259200000},"content-version":"am","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"abstract":"<jats:p>In this UK multicentre study of 54 patients with severe alopecia areata, 15 of 54 (28%) patients taking oral ritlecitinib 50\u2005mg daily achieved a success rate (SALT \u2264 20) at 6\u2005months, demonstrating real-world efficacy and safety profiles comparable with pivotal clinical trials. Notably, success was numerically lower in patients with skin of colour (13% vs. 33% in White patients), a subgroup that presented with significantly higher baseline disease severity and a higher likelihood of past diphenylcyclopropenone or systemic treatment.<\/jats:p>","DOI":"10.1093\/ced\/llag272","type":"journal-article","created":{"date-parts":[[2026,6,20]],"date-time":"2026-06-20T11:40:14Z","timestamp":1781955614000},"source":"Crossref","is-referenced-by-count":1,"title":["A multicentre real-world evaluation of ritlecitinib in severe alopecia areata: early real-world experience in a British cohort"],"prefix":"10.1093","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0111-1231","authenticated-orcid":false,"given":"Danning","family":"Li","sequence":"first","affiliation":[{"name":"Warwick Dermatology Centre, South Warwickshire University NHS Foundation Trust , Warwick ,","place":["UK"]},{"name":"University Hospitals Coventry and Warwickshire NHS Trust , Coventry ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Radhika","family":"Bhanot","sequence":"additional","affiliation":[{"name":"Warwick Dermatology Centre, South Warwickshire University NHS Foundation Trust , Warwick ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonika Sethi","family":"Nayyar","sequence":"additional","affiliation":[{"name":"Birmingham Skin Centre, Sandwell and West Birmingham NHS Trust , Birmingham ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vidette","family":"Wong","sequence":"additional","affiliation":[{"name":"University Hospitals Coventry and Warwickshire NHS Trust , Coventry ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kareem","family":"Hassanin","sequence":"additional","affiliation":[{"name":"Walsall Manor Hospital , Walsall ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Graciaa","family":"Singhal","sequence":"additional","affiliation":[{"name":"New Cross Hospital , Wolverhampton ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Elhabrouk","sequence":"additional","affiliation":[{"name":"Birmingham Skin Centre, Sandwell and West Birmingham NHS Trust , Birmingham ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donna","family":"Thompson","sequence":"additional","affiliation":[{"name":"Birmingham Skin Centre, Sandwell and West Birmingham NHS Trust , Birmingham ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Halpern","sequence":"additional","affiliation":[{"name":"Walsall Manor Hospital , Walsall ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9221-7618","authenticated-orcid":false,"given":"Simon","family":"Tso","sequence":"additional","affiliation":[{"name":"Warwick Dermatology Centre, South Warwickshire University NHS Foundation Trust , Warwick ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tang Ngee","family":"Shim","sequence":"additional","affiliation":[{"name":"University Hospitals Coventry and Warwickshire NHS Trust , Coventry ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5054-1225","authenticated-orcid":false,"given":"Kashini","family":"Andrew","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Worcestershire Acute Hospitals NHS Trust , Worcester ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,6,24]]},"reference":[{"key":"2026071610563621800_llag272-B1","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.jaad.2019.08.032","article-title":"Epidemiology of alopecia areata, ophiasis, totalis, and universalis: a systematic review and meta-analysis","volume":"82","author":"Lee","year":"2020","journal-title":"J Am Acad Dermatol"},{"key":"2026071610563621800_llag272-B2","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1016\/j.jaad.2016.08.042","article-title":"SALT II: a new take on the Severity of Alopecia Tool (SALT) for determining percentage scalp hair loss","volume":"75","author":"Olsen","year":"2016","journal-title":"J Am Acad Dermatol"},{"key":"2026071610563621800_llag272-B3","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1016\/S0140-6736(23)00222-2","article-title":"Efficacy and safety of ritlecitinib in adults and adolescents with alopecia areata: a randomised, double-blind, multicentre, phase 2b\u20133 trial","volume":"401","author":"King","year":"2023","journal-title":"Lancet"},{"key":"2026071610563621800_llag272-B4","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1001\/jamadermatol.2023.0016","article-title":"Overall and racial and ethnic subgroup prevalences of alopecia areata, alopecia totalis, and alopecia universalis","volume":"159","author":"Sy","year":"2023","journal-title":"JAMA Dermatol"},{"key":"2026071610563621800_llag272-B5","doi-asserted-by":"crossref","first-page":"1866","DOI":"10.1093\/ced\/llaf194","article-title":"Ritlecitinib in clinical practice: a real-world study of efficacy, safety and prior Janus kinase inhibitor impact in alopecia areata","volume":"50","author":"R","year":"2025","journal-title":"Clin Exp Dermatol"}],"container-title":["Clinical and Experimental Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ced\/advance-article-pdf\/doi\/10.1093\/ced\/llag272\/68589522\/llag272.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ced\/advance-article-pdf\/doi\/10.1093\/ced\/llag272\/68589522\/llag272.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T14:56:41Z","timestamp":1784213801000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ced\/advance-article\/doi\/10.1093\/ced\/llag272\/8714957"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,24]]},"references-count":5,"URL":"https:\/\/doi.org\/10.1093\/ced\/llag272","relation":{},"ISSN":["0307-6938","1365-2230"],"issn-type":[{"value":"0307-6938","type":"print"},{"value":"1365-2230","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,24]]},"article-number":"llag272"}}